Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun:24:124-131.
doi: 10.1016/j.coviro.2017.06.003. Epub 2017 Jun 30.

Host determinants of adeno-associated viral vector entry

Affiliations
Review

Host determinants of adeno-associated viral vector entry

Sirika Pillay et al. Curr Opin Virol. 2017 Jun.

Abstract

Viral vectors based on adeno-associated virus (AAV) are leading candidates for therapeutic gene delivery. Understanding rate-limiting steps in the entry of AAV vectors may be used in a rational approach to improve efficiency and specificity of transduction. This review describes our current understanding of AAV entry, a key step during infection. We discuss the identity and functions of AAV receptors and attachment factors, including the recently discovered multi-serotype receptor AAVR. We further provide an overview of other host factors that act during the trafficking stage of AAV vector transduction. In particular, we focus on cellular protein complexes associated with retrograde transport from endosomes to the trans-Golgi network. The novel insights in AAV-host interactions facilitated by technological advances in genetic screening approaches provide a greater depth in our understanding how AAV vectors exploit host factors to deliver its genetic cargo to the nucleus.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Sirika Pillay and Jan E. Carette are inventors on a patent owned by Stanford University on the uses of AAVR in gene therapy.

Figures

Figure 1
Figure 1
Schematic representation of the possible roles of AAVR in the AAV life cycle - (i) AAV binds to HSPG, allowing subsequent interaction with AAVR at the cell surface, which facilitates entry into the endosomal network; (ii) AAVR interacts with AAV in the endosomal system and facilitates trafficking to the trans-Golgi. (iii) Once in the trans-Golgi network, AAVR facilitates AAV escape into the cytoplasm.

References

    1. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003;4:346–358. - PubMed
    1. Naldini L. Gene therapy returns to centre stage. Nature. 2015;526:351–360. - PubMed
    1. Hastie E, Samulski RJ. Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success–a personal perspective. Hum Gene Ther. 2015;26:257–265. - PMC - PubMed
    1. Atchison RW, Casto BC, Hammon WM. Adenovirus-Associated Defective Virus Particles. Science. 1965;149:754–756. - PubMed
    1. Geoffroy MC, Salvetti A. Helper functions required for wild type and recombinant adeno-associated virus growth. Curr Gene Ther. 2005;5:265–271. - PubMed

Substances